Find Rilpivirine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

VMF

NDC API

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

API REF. PRICE (USD/KG)

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 500287-72-9, Tmc278, Edurant, Rilpivirine free base, R278474, Tmc 278
Molecular Formula
C22H18N6
Molecular Weight
366.4  g/mol
InChI Key
YIBOMRUWOWDFLG-ONEGZZNKSA-N
FDA UNII
FI96A8X663

Rilpivirine
A diarylpyrimidine derivative and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 that is used in the treatment of HIV INFECTIONS. It is also used in combination with other ANTI-HIV AGENTS, since ANTIVIRAL DRUG RESISTANCE emerges rapidly when it is used alone.
Rilpivirine is a Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor. The mechanism of action of rilpivirine is as a Non-Nucleoside Reverse Transcriptase Inhibitor.
1 2D Structure

Rilpivirine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile
2.1.2 InChI
InChI=1S/C22H18N6/c1-15-12-18(4-3-10-23)13-16(2)21(15)27-20-9-11-25-22(28-20)26-19-7-5-17(14-24)6-8-19/h3-9,11-13H,1-2H3,(H2,25,26,27,28)/b4-3+
2.1.3 InChI Key
YIBOMRUWOWDFLG-ONEGZZNKSA-N
2.1.4 Canonical SMILES
CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N
2.1.5 Isomeric SMILES
CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)/C=C/C#N
2.2 Other Identifiers
2.2.1 UNII
FI96A8X663
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 278, Tmc

2. Hcl, Rilpivirine

3. Hydrochloride, Rilpivirine

4. R278474

5. Rilpivirine Hcl

6. Rilpivirine Hydrochloride

7. Tmc 278

8. Tmc-278

9. Tmc278

2.3.2 Depositor-Supplied Synonyms

1. 500287-72-9

2. Tmc278

3. Edurant

4. Rilpivirine Free Base

5. R278474

6. Tmc 278

7. Tmc-278

8. R 278474

9. (e)-4-((4-((4-(2-cyanovinyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile

10. (e)-4-(4-(4-(2-cyanovinyl)-2,6-dimethylphenylamino)pyrimidin-2-ylamino)benzonitrile

11. 4-{[4-({4-[(e)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile

12. 4-{[4-({4-[(e)-2-cyanovinyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile

13. Chebi:68606

14. Fi96a8x663

15. 500287-72-9 (free Base)

16. 4-[[4-[[4-[(e)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzonitrile

17. Db08864

18. R-278474

19. Rilpivirine [inn]

20. Rilpivirine [usan:inn]

21. Rilpivirina

22. Unii-fi96a8x663

23. Hsdb 8153

24. Edurant(tm)

25. 4-((4-((4-((1e)-2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrile

26. 4-[[4-[[4-[(1e)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile

27. T27

28. Rilpivirine [mi]

29. Rilpivirine [jan]

30. Rilpivirine [usan]

31. Rilpivirine [vandf]

32. Rilpivirine [mart.]

33. Rilpivirine [who-dd]

34. Schembl384696

35. Schembl385113

36. Rilpivirine (jan/usan/inn)

37. Chembl175691

38. Gtpl11387

39. Dtxsid10198189

40. Ex-a245

41. Rilpivirine [orange Book]

42. Bdbm222178

43. Bcp03563

44. Zinc1554274

45. Cabenuva Component Rilpivirine

46. Mfcd11046372

47. S7303

48. Stl484047

49. Akos015901680

50. Bcp9000016

51. Ccg-268241

52. Cs-0440

53. Ke-0036

54. R278474;tmc278

55. 4-[[4-[4-[(e)-2-cyanovinyl]-2,6-dimethyl-anilino]pyrimidin-2-yl]amino]benzonitrile

56. Rilpivirine Component Of Cabenuva

57. Ncgc00319175-03

58. Ncgc00319175-08

59. Rilpivirine(r 278474, Tmc 278)

60. Ac-30619

61. Hy-10574

62. Bcp0726000192

63. Sw220232-1

64. D09720

65. A827939

66. Q421547

67. W-202888

68. 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]pyrimidine-2-yl]amino]benzonitrile

69. 4-[[4-[4-[(e)-2-cyanoethenyl]-2,6-dimethylanilino]-2-pyrimidinyl]amino]benzonitrile

70. 4-{4-[4-((e)-2-cyano-vinyl)-2,6-dimethyl-phenylamino]-pyrimidin-2-ylamino}-benzonitrile

71. (e)-3-{4-[2-(p-cyanophenylamino)-4-pyrimidinylamino]-3,5-xylyl}acrylonitrile; 4-[[4-[[4-[(1e)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile

72. 4-((4-((4-((1e)-2-cyanoethenyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile

73. 4-[[4-[[4-[(e)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile

74. Benzonitrile, 4-((4-((4-((1e)-2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2- Pyrimidinyl)amino)-

75. Benzonitrile, 4-((4-((4-((1e)-2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)-

2.4 Create Date
2006-04-29
3 Chemical and Physical Properties
Molecular Weight 366.4 g/mol
Molecular Formula C22H18N6
XLogP34.5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count5
Exact Mass366.15929460 g/mol
Monoisotopic Mass366.15929460 g/mol
Topological Polar Surface Area97.4 Ų
Heavy Atom Count28
Formal Charge0
Complexity607
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameEdurant
PubMed HealthRilpivirine (By mouth)
Drug ClassesAntiretroviral Agent
Active IngredientRilpivirine hydrochloride
Dosage FormTablet
RouteOral
Strengtheq 25mg base
Market StatusPrescription
CompanyJanssen Prods

2 of 2  
Drug NameEdurant
PubMed HealthRilpivirine (By mouth)
Drug ClassesAntiretroviral Agent
Active IngredientRilpivirine hydrochloride
Dosage FormTablet
RouteOral
Strengtheq 25mg base
Market StatusPrescription
CompanyJanssen Prods

4.2 Therapeutic Uses

HIV Reverse Transcriptase/antagonists & inhibitors

National Library of Medicine's Medical Subject Headings. Rilpivirine. Online file (MeSH, 2014). Available from, as of November 19, 2013: https://www.nlm.nih.gov/mesh/2014/mesh_browser/MBrowser.html


Due to ongoing neuropsychiatric adverse events in some efavirenz (EFV)-treated patients, a switch to an alternative non-nucleoside reverse transcriptase inhibitor may be considered. Rilpivirine (RPV) has been coformulated as a single-tablet regimen (STR) with emtricitabine/tenofovir disoproxil fumarate (FTC/TDF), and the components have demonstrated noninferior efficacy to EFV+FTC/TDF, good tolerability profile, and high adherence. After discontinuation, EFV has an extended inductive effect on cytochrome P450 (CYP) 3A4 that, after switching, may reduce RPV exposures and adversely impact clinical outcomes. This study examines the clinical implications of reduced RPV exposures with concomitant FTC/TDF and declining EFV exposures when patients, intolerant to EFV, switch from EFV/FTC/TDF to RPV/FTC/TDF. This 48-week, phase 2b, open-label, multicenter study evaluated the efficacy and safety of switching from EFV/FTC/TDF (>/= 3 months duration) to RPV/FTC/TDF. Virologic suppression (HIV-1 RNA <50 copies/mL), safety, and EFV and RPV pharmacokinetics were assessed. At weeks 12 and 24, all 49 dosed subjects remained suppressed on RPV/FTC/TDF. At week 48, 46 (93.9%) subjects remained suppressed and virologic failure occurred in 2/49 (4.1%) subjects with no emergence of resistance. EFV concentrations were above the 90th percentile for inhibitory concentration (IC90) for several weeks after EFV discontinuation, and RPV exposures were in the range observed in phase 3 studies by approximately 2 weeks post switch. No subjects discontinued the study due to an adverse event. Switching from EFV/FTC/TDF to RPV/FTC/ TDF was a safe, efficacious option for virologically suppressed HIV-infected patients with EFV intolerance wishing to remain on an STR.

PMID:24144898 Mills AM et al; HIV Clin Trials 14 (5): 216-23 (2013)


4.3 Drug Warning

Adverse effects of moderate or severe intensity and reported in 2% or more of patients receiving rilpivirine include depressive disorders, insomnia, headache, and rash. Increased serum AST and/or ALT concentrations (more than 2.5 times the upper limit of normal (ULN) were reported in 3-4% of patients receiving rilpivirine.

American Society of Health-System Pharmacists 2013; Drug Information 2013. Bethesda, MD. 2013, p. 680


Rilpivirine should be used with caution and with increased monitoring for adverse effects in patients with severe renal impairment or end-stage renal disease since concentrations of the drug may be increased due to alterations in absorption, distribution, or metabolism.

American Society of Health-System Pharmacists 2013; Drug Information 2013. Bethesda, MD. 2013, p. 680


Rilpivirine and the fixed combination containing rilpivirine, emtricitabine, and tenofovir (Complera) have not been studied in patients with severe hepatic impairment (Child-Pugh class C).

American Society of Health-System Pharmacists 2013; Drug Information 2013. Bethesda, MD. 2013, p. 680


Experience in those 65 years of age and older is insufficient to determine whether they respond differently than younger adults. Dosage should be selected with caution because of age-related decreases in hepatic and/or renal function and potential for concomitant disease and drug therapy.

American Society of Health-System Pharmacists 2013; Drug Information 2013. Bethesda, MD. 2013, p. 680


For more Drug Warnings (Complete) data for Rilpivirine (13 total), please visit the HSDB record page.


4.4 Drug Indication

Rilpivirine, in combination with other agents, is indicated for the treatment of HIV-1 infections in antiretroviral treatment-naive patients with HIV-1 RNA 100,000 copies/mL and CD4+ cell count >200 cells/mm3. The FDA combination therapy approval of rilpivirine and dolutegravir is indicated for adults with HIV-1 infections whose virus is currently suppressed (< 50 copies/ml) on a stable regimen for at least six months, without history of treatment failure and no known substitutions associated to resistance to any of the two components of the therapy.


FDA Label


Edurant, in combination with other antiretroviral medicinal products, is indicated for the treatment of human immunodeficiency virus type 1 (HIV1) infection in antiretroviral treatmentnave patients 12 years of age and older with a viral load 100,000 HIV1 RNA copies/ml.

As with other antiretroviral medicinal products, genotypic resistance testing should guide the use of Edurant.


Treatment of human immunodeficiency virus (HIV-1) infection


Rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (HIV 1) infection in adults who are virologically suppressed (HIV-1 RNA < 50 copies/mL) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the NNRTI and INI class.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Rilpivirine is a non-nucleoside reverse transcriptase inhibitor that inhibits the replication of HIV-1. It has a long duration of action as the oral tablet is given daily and the intramuscular suspension is given monthly. Patients should be counselled regarding the risk of hypersensitivity reactions, hepatotoxicity, depressive disorders, and the redistribution or accumulation of body fat.


5.2 MeSH Pharmacological Classification

Anti-HIV Agents

Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)


Reverse Transcriptase Inhibitors

Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
RILPIVIRINE
5.3.2 FDA UNII
FI96A8X663
5.3.3 Pharmacological Classes
Non-Nucleoside Analog [EXT]
5.4 ATC Code

J05AG05


J05AG05


J05AG05

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


J - Antiinfectives for systemic use

J05 - Antivirals for systemic use

J05A - Direct acting antivirals

J05AG - Non-nucleoside reverse transcriptase inhibitors

J05AG05 - Rilpivirine


5.5 Absorption, Distribution and Excretion

Absorption

Rilpivirine has a Tmax of 3-4 hours and has a mean AUC of 2235 851 ng\*h/mL. A 25mg dose reaches a Cmax of 247 ng/mL in healthy subjects and 138.6 ng/mL in patients with HIV-1.


Route of Elimination

Rilpivirine is 85% eliminated in the feces and 6.1% eliminated in the urine. 25% of a dose is recovered in the feces as the unchanged parent drug, while <1% of a dose is recovered in the urine as the unchanged parent drug.


Volume of Distribution

In HIV-1 patients, the apparent volume of distribution in the central compartment was 152-173 L.


Clearance

In HIV-1 patients, the apparent total clearance is estimated to be 6.89-8.66 L/h.


After a single oral dose, an average of 85% of the dose is eliminated in feces (75% as metabolites) and 6% is eliminated in urine (only trace amounts as unchanged rilpivirine).

American Society of Health-System Pharmacists 2013; Drug Information 2013. Bethesda, MD. 2013, p. 681


It is not known whether rilpivirine is distributed into human milk; however, the drug is distributed into milk in rats.

American Society of Health-System Pharmacists 2013; Drug Information 2013. Bethesda, MD. 2013, p. 680


5.6 Metabolism/Metabolites

Rilpivirine is predominantly metabolized by CYP3A4 and CYP3A5 to the hydroxylated metabolites M1, M2, M3, and M4. UGT1A1 glucuronidates the M2 metabolite to form M6, UGT1A4 glucuronidates rilpivirine to form M5, and an unknown UGT glucuronidates the M4 metabolite to form M7.


Rilpivirine is metabolized by the cytochrome P-450 (CYP) isoenzyme 3A.

American Society of Health-System Pharmacists 2013; Drug Information 2013. Bethesda, MD. 2013, p. 680


5.7 Biological Half-Life

Rilpivirine has a terminal half-life of 34-55 hours.


The terminal elimination half-life of rilpivirine is approximately 50 hours.

American Society of Health-System Pharmacists 2013; Drug Information 2013. Bethesda, MD. 2013, p. 681


5.8 Mechanism of Action

Rilpivirine is a non-competitive NNRTI that binds to reverse transcriptase. Its binding results in the blockage of RNA and DNA- dependent DNA polymerase activities, like HIV-1 replication. It does not present activity against human DNA polymerases , and . Rilpivirine's flexible structure around the aromatic rings allows the adaptation to changes in the non-nucleoside RT binding pocket, reducing the likelihood of viral mutations conferring resistance.


Rilpivirine, a diarylpyrimidine nonnucleoside reverse transcriptase inhibitor (NNRTI), inhibits replication of human immunodeficiency virus type 1 (HIV-1) by interfering with viral RNA- and DNA-directed polymerase activities of reverse transcriptase. Diarylpyrimidine NNRTIs (e.g., rilpivirine, etravirine) are capable of adapting to mutations in HIV-1 reverse transcriptase because of structural flexibility that allows for binding to the allosteric NNRTI binding pocket in a variety of conformations. Unlike other currently available NNRTIs, rilpivirine contains a cyanovinyl group that contributes to potency and maintains the drug's binding ability, despite the emergence of some resistance mutations.

American Society of Health-System Pharmacists 2013; Drug Information 2013. Bethesda, MD. 2013, p. 681


API SUPPLIERS

read-more
read-more

01

Minakem

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Minakem Comapny Banner

02

ChemWerth Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Chemwerth Compnay Banner

03

Minakem (formerly Delmar Chemicals...

Canada

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem is manufacturing small molecules APIs including corticosteroids

Flag Canada
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Minakem Delmar

04

Minakem (formerly Delmar Chemicals...

Canada

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem is manufacturing small molecules APIs including corticosteroids

Flag Canada
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Minakem Delmar

05

Cipla

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Cipla

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

06

Johnson & Johnson Innovative Medic...

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCI Medicinal Chemistry
Not Confirmed
arrow

Johnson & Johnson Innovative Medic...

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCI Medicinal Chemistry
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

07

Johnson & Johnson Innovative Medic...

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCI Medicinal Chemistry
Not Confirmed
arrow

Johnson & Johnson Innovative Medic...

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCI Medicinal Chemistry
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Hetero Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCI Medicinal Chemistry
Not Confirmed
arrow

Hetero Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCI Medicinal Chemistry
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

09

Laurus Labs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCI Medicinal Chemistry
Not Confirmed
arrow

Laurus Labs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCI Medicinal Chemistry
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Anhui Biochem Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCI Medicinal Chemistry
Not Confirmed
arrow

Anhui Biochem Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCI Medicinal Chemistry
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

02

NASP
Not Confirmed

04

NASP
Not Confirmed

04

Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

SCI Medicinal Chemistry
Not Confirmed
arrow
arrow
SCI Medicinal Chemistry
Not Confirmed

Rilpivirine

Registrant Name : Korea Janssen Co., Ltd.

Registration Date : 2021-11-08

Registration Number : Su81-25-ND

Manufacturer Name : Synergy Health Ede BV@Jansse...

Manufacturer Address : Soevereinstraat 2, Etten-Leur 4879NN, Netherlands@Janssen Pharmaceuticalaan 3, Geel, ...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content

RILPIVIRINE

NDC Package Code : 70219-0002

Start Marketing Date : 2024-03-18

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Minakem Comapny Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem is manufacturing small molecules APIs including corticosteroids

Flag Canada
Digital Content Digital Content

RILPIVIRINE

NDC Package Code : 11712-822

Start Marketing Date : 2024-11-11

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Minakem Delmar

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem is manufacturing small molecules APIs including corticosteroids

Flag Canada
Digital Content Digital Content

RILPIVIRINE

NDC Package Code : 11712-823

Start Marketing Date : 2025-02-04

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Minakem Delmar

05

SCI Medicinal Chemistry
Not Confirmed
arrow
arrow
SCI Medicinal Chemistry
Not Confirmed

RILPIVIRINE

NDC Package Code : 65977-0156

Start Marketing Date : 2011-05-20

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

SCI Medicinal Chemistry
Not Confirmed
arrow
arrow
SCI Medicinal Chemistry
Not Confirmed

RILPIVIRINE

NDC Package Code : 12578-622

Start Marketing Date : 2021-01-21

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

SCI Medicinal Chemistry
Not Confirmed
arrow
arrow
SCI Medicinal Chemistry
Not Confirmed

RILPIVIRINE

NDC Package Code : 50370-0057

Start Marketing Date : 2024-03-28

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

Synergy Health AST, LLC

Country
SCI Medicinal Chemistry
Not Confirmed
arrow

Synergy Health AST, LLC

Country
arrow
SCI Medicinal Chemistry
Not Confirmed

RILPIVIRINE

NDC Package Code : 71161-154

Start Marketing Date : 2025-03-13

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (300mg/300mg)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Minakem

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content

Rilpivirine

About the Company : MINAKEM is a cGMP custom manufacturer of small molecule API, HPAPI and steroids. All development and manufacturing activities are supported by highly skilled R&D teams, supported b...

MINAKEM is a cGMP custom manufacturer of small molecule API, HPAPI and steroids. All development and manufacturing activities are supported by highly skilled R&D teams, supported by strong analytical and regulatory affairs services. The R&D team has an expertise in process development, organic synthesis, and works under a secrecy agreement to protect your IP. With 3 production sites in Europe and 1 in Canada, Minakem is ready to support your strategic sourcing projects or your reshoring activities. Recently launched commercial generic API: Apixaban, Mirabegron, Fulvestrant, remifentanil, esmolol,
Minakem Comapny Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Flag U.S.A
Digital Content Digital Content

Rilpivirine

About the Company : Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs ...

Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs to regulated markets worldwide and has exclusive partnerships for new product development, compliance support and secure supply chain logistics. ChemWerth has access to over 500 APIs and more than 30 manufacturing facilities in the US, Europe, India and China. ChemWerth acts as a regulatory agent for over 25 FDA-approved facilities and sells more than 100 products. It has established its presence in 38 countries. In 2020, ChemWerth filed its 500th DMF with the FDA.
Chemwerth Compnay Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem is manufacturing small molecules APIs including corticosteroids

Flag Canada
Digital Content Digital Content

Rilpivirine

About the Company : Minakem Montreal is developing and manufacturing small molecules APIs and advanced intermediates, including corticosteroids. Following efficient processes and methodologies, our em...

Minakem Montreal is developing and manufacturing small molecules APIs and advanced intermediates, including corticosteroids. Following efficient processes and methodologies, our employees operate a regularly inspected cGMP facility equipped with reactors ranging from 40 to 7,600 litres. Located in Montreal, Canada, we have contributed to the success of our North-American and international clients since 1964.
Minakem Delmar

04

NASP
Not Confirmed
arrow
arrow
NASP
Not Confirmed

Rilpivirine

About the Company : Anhui Biochem Pharmaceutical Co., Ltd. is a high tech enterprise which has integrated R&D, production and marketing specializing in synthetic technology of chiral compounds. We has...

Anhui Biochem Pharmaceutical Co., Ltd. is a high tech enterprise which has integrated R&D, production and marketing specializing in synthetic technology of chiral compounds. We has complete industry chain from API to FPPs products. We also have the largest, most complete line of anti-AIDS&HBV API Production facilities. The API products include Lamivudine USP, Zidovudine USP, Ritonavir USP, lopinavir, Nevirapine USP, Tenofovir Disoproxil Fumarate, Entecavir, NGF(Mouse Nerve Growth Factor), Capecitabine and other intermediates. The FPPs products include Lamivudine Tablet(100mg/150mg/300mg)
blank

05

NASP
Not Confirmed
arrow
arrow
NASP
Not Confirmed

Rilpivirine

About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...

Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Excipients, Herbal extracts, Formulation of Chinese & Western Medicine. With abundant economic strength, the group has successfully developed to a pharmaceutical group enterprise wich intergrets operation of medicine & related products, processing & manufacturing, and importation & exportation together.
blank

06

Laurus Labs

India
NASP
Not Confirmed
arrow

Laurus Labs

India
arrow
NASP
Not Confirmed

Rilpivirine

About the Company : Laurus Labs is a leading research and development-driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of Active Ph...

Laurus Labs is a leading research and development-driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. Laurus Labs also manufactures APIs in oncology and other therapeutic areas. Its strategic and early investments in R&D and manufacturing infrastructure have enabled it to become one of the leading suppliers of APIs in the ARV therapeutic area. Out of Ten largest generic pharmaceutical companies in the world, by revenues, are our customers.
blank

07

NASP
Not Confirmed
arrow
arrow
NASP
Not Confirmed

Rilpivirine

About the Company : Syntame is a Pharm- Heatlh technology company jointly sponsored by two PhD from Hong Kong Polytechnic University & Zhejiang University. We always focus on the market & customer nee...

Syntame is a Pharm- Heatlh technology company jointly sponsored by two PhD from Hong Kong Polytechnic University & Zhejiang University. We always focus on the market & customer needs, committee to researching, developing & marketing innovative products & services of pharmaceutical & health. Our Pharmaceutical Division: Committed to the R&D, promotion, distribution of APIs & intermediates, to provide various innovative products & technical solutions for China & global pharmaceutical markets. Our Health Division: Continuously tapping the natural active ingredients, combining traditional Chinese medicine theory, to develop functional foods.
blank

08

NASP
Not Confirmed
arrow
arrow
NASP
Not Confirmed

Rilpivirine

About the Company : Sichuan Renan Pharmaceutical Co., Ltd., founded in June 2013 with 325 acres and more than 1000 employees , located in Yuechi Pharmaceutical Industrial Park, Guangan city Sichuan pr...

Sichuan Renan Pharmaceutical Co., Ltd., founded in June 2013 with 325 acres and more than 1000 employees , located in Yuechi Pharmaceutical Industrial Park, Guangan city Sichuan province,China , is a wholly-owned subsidiary of Chengdu Brilliant Pharmaceutical Co., Ltd group. Renan Pharma is PMDA and EU approved , it is a high-tech innovative enterprise committed to the research & development, producing and sales of high-tech APIs and intermediates for global.
blank

09

NASP
Not Confirmed
arrow
arrow
NASP
Not Confirmed

Rilpivirine

About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and...

Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1644863400,"product":"RILPIVIRINE HYDROCHLORIDE (TAX INVOICE N","address":"MSN HOUSE ,PLOT NO. C-24, INDUSTRIAL ESTATE,SANATHNAGAR,HYDER","city":"HYDERABAD","supplier":"MSN PHARMACHEM PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"PRAGUE - RUZYNE","customer":"ZENTIVA KS","customerCountry":"CZECH REPUBLIC","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"4000","totalValueFC":"19571.2","currency":"USD","unitRateINR":293400,"date":"15-Feb-2022","totalValueINR":"1467000","totalValueInUsd":"19571.2","indian_port":"HYDERABAD AIR","hs_no":"29335990","bill_no":"8229991","productDescription":"API","marketType":"REGULATED MARKET","country":"CZECH REPUBLIC","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE ,PLOT NO. C-24, INDUSTRIAL ESTATE,SANATHNAGAR,HYDER, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655058600,"product":"RILPIVIRINE HYDROCHLORIDE (TAX INV NO:29","address":"MSN HOUSE ,PLOT NO. C-24, INDUSTRIAL ESTATE,SANATHNAGAR,HYDER","city":"HYDERABAD","supplier":"MSN PHARMACHEM PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"UNDISCLOSED","customerCountry":"CANADA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"2500","totalValueFC":"4781.1","currency":"USD","unitRateINR":186500,"date":"13-Jun-2022","totalValueINR":"373000","totalValueInUsd":"4781.1","indian_port":"HYDERABAD AIR","hs_no":"29335990","bill_no":"2072949","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE ,PLOT NO. C-24, INDUSTRIAL ESTATE,SANATHNAGAR,HYDER, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676572200,"product":"RILPIVIRINE HCL","address":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA","city":"VISAKHAPATNAM,ANDHRA PRADESH","supplier":"LAURUS LABS LTD","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"EVA PHARMA FOR PHARMACEUTICAL INDUS","customerCountry":"EGYPT","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"2100","totalValueFC":"4092.5","currency":"USD","unitRateINR":169000,"date":"17-Feb-2023","totalValueINR":"338000","totalValueInUsd":"4092.5","indian_port":"HYDERABAD AIR","hs_no":"29141990","bill_no":"7858799","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA, VISAKHAPATNAM,ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1690137000,"product":"RILPIVIRINE","address":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA","city":"VISAKHAPATNAM,ANDHRA PRADESH","supplier":"LAURUS LABS LTD","supplierCountry":"INDIA","foreign_port":"MONTREAL-DORAVAL APT","customer":"PHARMASCIENCE INC","customerCountry":"CANADA","quantity":"0.90","actualQuantity":"900","unit":"GMS","unitRateFc":"5","totalValueFC":"4051.6","currency":"USD","unitRateINR":369.99963000000002,"date":"24-Jul-2023","totalValueINR":"332999.667","totalValueInUsd":"4051.6","indian_port":"HYDERABAD AIR","hs_no":"29335990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOTNO21JAWAHARLAL NEHRU PHARMACIT Y,PARAWADA, VISAKHAPATNAM,ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1692642600,"product":"RILPIVIRINE","address":"PLOT NO. C-24 INDUSTRIAL ESTATE SANATH NAGAR","city":"Hyderabad","supplier":"MSN PHARMACHEM PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNDISCLOSED","customerCountry":"CANADA","quantity":"0.90","actualQuantity":"0.9","unit":"KGS","unitRateFc":"19762.1","totalValueFC":"17649.3","currency":"USD","unitRateINR":1624444.4377777777,"date":"22-Aug-2023","totalValueINR":"1461999.994","totalValueInUsd":"17649.3","indian_port":"HYDERABAD ICD","hs_no":"29335990","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD ICD","supplierAddress":"PLOT NO. C-24 INDUSTRIAL ESTATE SANATH NAGAR, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705861800,"product":"RILPIVIRINE HYDROCHLORIDE","address":"PLOT NO. C-24, INDUSTRIAL ESTATE,","city":"HYDERABAD. AP","supplier":"MSN PHARMACHEM PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"APOTEX INC ETOBICOKE","customerCountry":"CANADA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"2000","totalValueFC":"1843.2","currency":"USD","unitRateINR":153190,"date":"22-Jan-2024","totalValueINR":"153190","totalValueInUsd":"1843.2","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"6922410","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO. C-24, INDUSTRIAL ESTATE,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1719340200,"product":"RILPIVIRINE","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"CIPLA LTD","supplierCountry":"INDIA","foreign_port":"COLUMBUS, OH","customer":"AMERICAN REGENT","customerCountry":"UNITED STATES","quantity":"1.50","actualQuantity":"1500","unit":"GMS","unitRateFc":"45","totalValueFC":"66576.3","currency":"USD","unitRateINR":3705.1669466666667,"date":"26-Jun-2024","totalValueINR":"5557750.42","totalValueInUsd":"66576.3","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"1953812","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"MUMBAI CENTRAL,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720204200,"product":"RILPIVIRINE BATCH NO.RD-298-1301-031-S1","address":"NIKITA BAUNGLOW, NEAR PRAGATI","city":"GUJARAT","supplier":"APOTHECON PHARMACEUTICALS PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"NEW YORK - JOHN F. K","customer":"GYMA LABORATORIES OF AMERICA INC","customerCountry":"UNITED STATES","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"5000","totalValueFC":"4879.3","currency":"USD","unitRateINR":407868.53999999998,"date":"06-Jul-2024","totalValueINR":"407868.54","totalValueInUsd":"4879.3","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"2220861","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"NIKITA BAUNGLOW, NEAR PRAGATI, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720204200,"product":"RILPIVIRINE BATCH NO.RD-298-1301-037-S1","address":"NIKITA BAUNGLOW, NEAR PRAGATI","city":"GUJARAT","supplier":"APOTHECON PHARMACEUTICALS PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"NEW YORK - JOHN F. K","customer":"GYMA LABORATORIES OF AMERICA INC","customerCountry":"UNITED STATES","quantity":"1.10","actualQuantity":"1.1","unit":"KGS","unitRateFc":"5000","totalValueFC":"5367.3","currency":"USD","unitRateINR":407868.50909090904,"date":"06-Jul-2024","totalValueINR":"448655.36","totalValueInUsd":"5367.3","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"2220861","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"NIKITA BAUNGLOW, NEAR PRAGATI, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729103400,"product":"RILPIVIRINEBATCH NO : RD-298-1276-139-S1","address":"NIKITA BAUNGLOW, NEAR PRAGATI","city":"GUJARAT","supplier":"APOTHECON PHARMACEUTICALS PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"GYMA LABORATORIES OF AMERICA INC","customerCountry":"UNITED STATES","quantity":"0.10","actualQuantity":"0.095","unit":"KGS","unitRateFc":"5000","totalValueFC":"380.8","currency":"USD","unitRateINR":336773.68421052629,"date":"17-Oct-2024","totalValueINR":"31993.5","totalValueInUsd":"380.8","indian_port":"Ahmedabad Air","hs_no":"29339990","bill_no":"4897196","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"NIKITA BAUNGLOW, NEAR PRAGATI, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1730917800,"product":"RILPIVIRINE HCI","address":"2ND FLOOR, SERENE CHAMBERS,","city":"N\/A","supplier":"LAURUS LABS LTD","supplierCountry":"INDIA","foreign_port":"PRAGUE - RUZYNE","customer":"ZENTIVA KS","customerCountry":"CZECH REPUBLIC","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"2300","totalValueFC":"11219.7","currency":"USD","unitRateINR":189362.20199999999,"date":"07-Nov-2024","totalValueINR":"946811.01","totalValueInUsd":"11219.7","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"5434184","productDescription":"API","marketType":"REGULATED MARKET","country":"CZECH REPUBLIC","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, SERENE CHAMBERS,, N\/A","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647628200,"product":"(N.C.V) JNJ-4754724-AAA,R311489 INTERMEDIATE OF RILPIVIRINEHYDROCHLORIDE BENZONITRILE ,4[(4-CHLORO-2-PYRIMIDINYL)AMINO]","address":"L.B.S. MARG,,MULUND-WEST","city":"MUMBAI,MAHARASHTRA","supplier":"JANSSEN PHARMACEUTICA NV","supplierCountry":"BELGIUM","foreign_port":"NA","customer":"JOHNSON JOHNSON PRIVATE LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.4","unit":"GMS","unitRateFc":"1327","totalValueFC":"595.1","currency":"EURO","unitRateINR":"113392.2","date":"19-Mar-2022","totalValueINR":"45356.86","totalValueInUsd":"595.1","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"7927914","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"L.B.S. MARG,,MULUND-WEST"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647628200,"product":"(N.C.V) JNJ-4754724-AAA,R311489 INTERMEDIATE OF RILPIVIRINEHYDROCHLORIDE BENZONITRILE ,4[(4-CHLORO-2-PYRIMIDINYL)AMINO]","address":"L.B.S. MARG,,MULUND-WEST","city":"MUMBAI,MAHARASHTRA","supplier":"JANSSEN PHARMACEUTICA NV","supplierCountry":"BELGIUM","foreign_port":"NA","customer":"JOHNSON JOHNSON PRIVATE LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.4","unit":"GMS","unitRateFc":"286","totalValueFC":"128.3","currency":"EURO","unitRateINR":"24438.7","date":"19-Mar-2022","totalValueINR":"9775.48","totalValueInUsd":"128.3","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"7927914","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"L.B.S. MARG,,MULUND-WEST"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1653244200,"product":"(N.C.V) INTERMEDIATE OF RILPIVIRINE HCL (JNJ-19376123-AAC\/T002594) 2-PROPENENITRILE,3-(4-AMINO-3,5-DIMETHYLPHENYL)-MONOH","address":"L.B.S. MARG,,MULUND-WEST","city":"MUMBAI,MAHARASHTRA","supplier":"JANSSEN PHARMACEUTICA NV","supplierCountry":"BELGIUM","foreign_port":"NA","customer":"JOHNSON JOHNSON PRIVATE LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"1","unit":"GMS","unitRateFc":"286","totalValueFC":"307.7","currency":"EURO","unitRateINR":"23780.9","date":"23-May-2022","totalValueINR":"23780.9","totalValueInUsd":"307.7","indian_port":"BOMBAY AIR","hs_no":"29215990","bill_no":"8791802","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"L.B.S. MARG,,MULUND-WEST"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1661365800,"product":"(N.C.V) JNJ-16150108-AAA,R278474 RILPIVIRINE BENZONITRILE,4-[[4-[[4-[(1E)-2-CYANOETHENYL]-2,6-DIMETHYLPHENYL]AMINO]-2-P","address":"L.B.S. MARG,,MULUND-WEST","city":"MUMBAI,MAHARASHTRA","supplier":"JANSSEN PHARMACEUTICA NV","supplierCountry":"BELGIUM","foreign_port":"NA","customer":"JOHNSON JOHNSON PRIVATE LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"4","unit":"GMS","unitRateFc":"286","totalValueFC":"1186.9","currency":"EURO","unitRateINR":"23609.3","date":"25-Aug-2022","totalValueINR":"94437.2","totalValueInUsd":"1186.9","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"2157099","productDescription":"API","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"L.B.S. MARG,,MULUND-WEST"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1663007400,"product":"(N.C.V) RILPIVIRINE HCL (FOR TESTING PURPOSE ONLY)","address":"L.B.S. MARG,,MULUND-WEST","city":"MUMBAI,MAHARASHTRA","supplier":"JANSSEN PHARMACEUTICAL SCIENCES UC","supplierCountry":"IRELAND","foreign_port":"NA","customer":"JOHNSON JOHNSON PRIVATE LTD","customerCountry":"INDIA","quantity":"0.47","actualQuantity":"467.64","unit":"GMS","unitRateFc":"2.3","totalValueFC":"1109.4","currency":"EURO","unitRateINR":"190.1","date":"13-Sep-2022","totalValueINR":"88909.45","totalValueInUsd":"1109.4","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"2414080","productDescription":"API","marketType":"REGULATED MARKET","country":"IRELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"L.B.S. MARG,,MULUND-WEST"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676572200,"product":"RILPIVIRINE HYDROCHLORIDE","address":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET","city":"HYDERABAD","supplier":"DESANO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"AUROBINDO PHARMA LTD","customerCountry":"INDIA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"2500","totalValueFC":"7596.3","currency":"USD","unitRateINR":"209125","date":"17-Feb-2023","totalValueINR":"627375","totalValueInUsd":"7596.3","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"4693353","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1682620200,"product":"(N.C.V) RILPIVIRINE (FOR TESTING PURPOSE ONLY)","address":"L.B.S. MARG,,MULUND-WEST","city":"MUMBAI,MAHARASHTRA","supplier":"JANSSEN PHARMACEUTICA NV","supplierCountry":"BELGIUM","foreign_port":"NA","customer":"JOHNSON JOHNSON PRIVATE LTD","customerCountry":"INDIA","quantity":"0.13","actualQuantity":"130","unit":"GMS","unitRateFc":"2.3","totalValueFC":"340.7","currency":"EURO","unitRateINR":"214.8","date":"28-Apr-2023","totalValueINR":"27925.56","totalValueInUsd":"340.7","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"5721820","productDescription":"API","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"L.B.S. MARG,,MULUND-WEST"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1687804200,"product":"(N.C.V)RILPIVIRINE HYDROCHLORIDE (FOR TESTING PURPOSE ONLY)","address":"L.B.S. MARG,,MULUND-WEST","city":"MUMBAI,MAHARASHTRA","supplier":"JANSSEN PHARMACEUTICAL SCIENCES UC","supplierCountry":"IRELAND","foreign_port":"NA","customer":"JOHNSON JOHNSON PRIVATE LTD","customerCountry":"INDIA","quantity":"0.55","actualQuantity":"551.65","unit":"GMS","unitRateFc":"2.3","totalValueFC":"1421.3","currency":"EURO","unitRateINR":"211.6","date":"27-Jun-2023","totalValueINR":"116822.419","totalValueInUsd":"1421.3","indian_port":"BOMBAY AIR","hs_no":"29359090","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"IRELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"L.B.S. MARG,,MULUND-WEST"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703269800,"product":"(N.C.V) RILPIVIRINE HYDROCHLORIDE (FOR TESTING PURPOSE ONLY)","address":"30 FORJETT STREET","city":"MUMBAI, MAHARASHTRA.","supplier":"JANSSEN PHARMACEUTICAL SCIENCE UC","supplierCountry":"IRELAND","foreign_port":"DUBLIN","customer":"JOHNSON JOHNSON PRIVATE LTD","customerCountry":"INDIA","quantity":"0.67","actualQuantity":"666.24","unit":"GMS","unitRateFc":"2.3","totalValueFC":"1729.6","currency":"EURO","unitRateINR":"216.1","date":"23-Dec-2023","totalValueINR":"143973.67","totalValueInUsd":"1729.6","indian_port":"Bombay Air","hs_no":"29359090","bill_no":"9384824","productDescription":"API","marketType":"REGULATED MARKET","country":"IRELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"DUBLIN","supplierAddress":"LITTLE ISLAND INDUSTRIAL ESTATE, LITTLE ISLAND CORK T45 P663SDNF Ireland","customerAddress":"30 FORJETT STREET"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708367400,"product":"RILPIVIRINE HYDROCHLORIDE","address":"PLOT NO.2, MAITRIVIHAR,","city":"HYDERABAD\/ANDHRA PRADESH","supplier":"DESANO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"AUROBINDO PHARMA LTD","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"2500","totalValueFC":"2527.9","currency":"USD","unitRateINR":"209750","date":"20-Feb-2024","totalValueINR":"209750","totalValueInUsd":"2527.9","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"2212456","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"NO. 1479 ZHANGHENG ROAD, ZHANGJIANGHI-TECH PARK, SHANGHAI 201203, CHI China","customerAddress":"PLOT NO.2, MAITRIVIHAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1714501800,"product":"(N.C.V) RILPIVIRINE HYDROCHLORIDE (FOR TESTING PURPOSE ONLY)","address":"30 FORJETT STREET","city":"MUMBAI, MAHARASHTRA.","supplier":"JANSSEN PHARMACEUTICAL SCIENCES UC","supplierCountry":"IRELAND","foreign_port":"DUBLIN","customer":"JOHNSON JOHNSON PRIVATE LTD","customerCountry":"INDIA","quantity":"0.57","actualQuantity":"570.8","unit":"GMS","unitRateFc":"2.3","totalValueFC":"1454.2","currency":"EURO","unitRateINR":"212.4","date":"01-May-2024","totalValueINR":"121212.03","totalValueInUsd":"1454.2","indian_port":"Bombay Air","hs_no":"29359090","bill_no":"3282531","productDescription":"API","marketType":"REGULATED MARKET","country":"IRELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"DUBLIN","supplierAddress":"LITTLE ISLAND INDUSTRIAL ESTATE LITTLE ISLAND CORK T45 P663 Little Island\/Cork, , Ireland Ireland","customerAddress":"30 FORJETT STREET"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1738866600,"product":"(N.C.V.) RILPIVIRINE (PACKAGING: PLASTIC BAG IN ALU BAG) (FOR TESTING PURPOSE ONLY)(N.C.V.) RILPIVIRINE (PACKAGING: PLASTIC BAG IN ALU BAG) (FO","address":"30 FORJETT STREET","city":"MUMBAI, MAHARASHTRA.","supplier":"JANSSEN PHARMACEUTICA NV","supplierCountry":"BELGIUM","foreign_port":"BRUSSELS","customer":"JOHNSON JOHNSON PRIVATE LTD","customerCountry":"INDIA","quantity":"0.13","actualQuantity":"130","unit":"GMS","unitRateFc":"2.5","totalValueFC":"324.3","currency":"EURO","unitRateINR":"216.9","date":"07-Feb-2025","totalValueINR":"28199.34","totalValueInUsd":"324.3","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"8220939","productDescription":"API","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"BRUSSELS","supplierAddress":"TURNHOUTSEWEG 30 B-2340 Beerse, , B elgium SDNF Belgium","customerAddress":"30 FORJETT STREET"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1750185000,"product":"(N.C.V.) ZR314585 RILPIVIRINE HYDROCHLORIDE AMBER JAR (FOR TESTING PURPOSE ONLY)(N.C.V.) ZR314585 RILPIVIRINE HYDROCHLORIDE AMBER JAR (FOR T","address":"30 FORJETT STREET","city":"MUMBAI, MAHARASHTRA.","supplier":"JANSSEN PHARMACEUTICAL SCIENCES UC","supplierCountry":"IRELAND","foreign_port":"DUBLIN","customer":"JOHNSON JOHNSON PRIVATE LTD","customerCountry":"INDIA","quantity":"0.47","actualQuantity":"472.92","unit":"GMS","unitRateFc":"2.7","totalValueFC":"1283.5","currency":"EURO","unitRateINR":"233.2","date":"18-Jun-2025","totalValueINR":"110282.34","totalValueInUsd":"1283.5","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"2722897","productDescription":"API","marketType":"REGULATED MARKET","country":"IRELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"DUBLIN","supplierAddress":"LITTLE ISLAND INDUSTRIAL ESTATE LIT TLE ISLAND CORK T45 P663 Little Isl and\/Cork, , Ireland Ireland","customerAddress":"30 FORJETT STREET"}]
15-Feb-2022
18-Jun-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

INTERMEDIATE SUPPLIERS

read-more
read-more

01

Vitafoods
Not Confirmed
arrow
Vitafoods
Not Confirmed
arrow

CAS Number : 661489-23-2

End Use API : Rilpivirine

About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...

blank

02

Vitafoods
Not Confirmed
arrow
Vitafoods
Not Confirmed
arrow

CAS Number : 3934-20-1

End Use API : Rilpivirine

About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...

blank

03

Vitafoods
Not Confirmed
arrow
Vitafoods
Not Confirmed
arrow

CAS Number : 244768-32-9

End Use API : Rilpivirine

About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...

blank

04

Vitafoods
Not Confirmed
arrow
Vitafoods
Not Confirmed
arrow

CAS Number : 189956-45-4

End Use API : Rilpivirine

About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...

blank

05

Vitafoods
Not Confirmed
arrow
Vitafoods
Not Confirmed
arrow

CAS Number : 24596-19-8

End Use API : Rilpivirine

About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...

blank

06

Vitafoods
Not Confirmed
arrow
Vitafoods
Not Confirmed
arrow

CAS Number : 4102-53-8

End Use API : Rilpivirine

About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...

blank

07

Vitafoods
Not Confirmed
arrow
Vitafoods
Not Confirmed
arrow

CAS Number : 189956-45-4

End Use API : Rilpivirine

About The Company : Glenfin Chemicals, a trusted provider of high-quality chemical solutions tailored to meet the diverse needs of industries worldwide. Based in the heart of inno...

blank

08

Vitafoods
Not Confirmed
arrow
Vitafoods
Not Confirmed
arrow

CAS Number : 5637-42-3

End Use API : Rilpivirine

About The Company : Ningbo Chemgoo is a R&D-driven company with core technology of organic chemistry, dedicating in technology development and industrialization. We provide interme...

blank

09

Vitafoods
Not Confirmed
arrow
Vitafoods
Not Confirmed
arrow

CAS Number : 189956-45-4

End Use API : Rilpivirine

About The Company : Ningbo Chemgoo is a R&D-driven company with core technology of organic chemistry, dedicating in technology development and industrialization. We provide interme...

blank

10

Vitafoods
Not Confirmed
arrow
Vitafoods
Not Confirmed
arrow

CAS Number : 244768-32-9

End Use API : Rilpivirine

About The Company : Ningbo Chemgoo is a R&D-driven company with core technology of organic chemistry, dedicating in technology development and industrialization. We provide interme...

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 500287-72-9 / Rilpivirine API manufacturers, exporters & distributors?

Rilpivirine manufacturers, exporters & distributors 1

29

PharmaCompass offers a list of Rilpivirine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rilpivirine manufacturer or Rilpivirine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rilpivirine manufacturer or Rilpivirine supplier.

PharmaCompass also assists you with knowing the Rilpivirine API Price utilized in the formulation of products. Rilpivirine API Price is not always fixed or binding as the Rilpivirine Price is obtained through a variety of data sources. The Rilpivirine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Rilpivirine

Synonyms

500287-72-9, Tmc278, Edurant, Rilpivirine free base, R278474, Tmc 278

Cas Number

500287-72-9

Unique Ingredient Identifier (UNII)

FI96A8X663

About Rilpivirine

A diarylpyrimidine derivative and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 that is used in the treatment of HIV INFECTIONS. It is also used in combination with other ANTI-HIV AGENTS, since ANTIVIRAL DRUG RESISTANCE emerges rapidly when it is used alone.

Rilpivirine Manufacturers

A Rilpivirine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rilpivirine, including repackagers and relabelers. The FDA regulates Rilpivirine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rilpivirine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Rilpivirine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Rilpivirine Suppliers

A Rilpivirine supplier is an individual or a company that provides Rilpivirine active pharmaceutical ingredient (API) or Rilpivirine finished formulations upon request. The Rilpivirine suppliers may include Rilpivirine API manufacturers, exporters, distributors and traders.

click here to find a list of Rilpivirine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Rilpivirine USDMF

A Rilpivirine DMF (Drug Master File) is a document detailing the whole manufacturing process of Rilpivirine active pharmaceutical ingredient (API) in detail. Different forms of Rilpivirine DMFs exist exist since differing nations have different regulations, such as Rilpivirine USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Rilpivirine DMF submitted to regulatory agencies in the US is known as a USDMF. Rilpivirine USDMF includes data on Rilpivirine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rilpivirine USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Rilpivirine suppliers with USDMF on PharmaCompass.

Rilpivirine KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Rilpivirine Drug Master File in Korea (Rilpivirine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Rilpivirine. The MFDS reviews the Rilpivirine KDMF as part of the drug registration process and uses the information provided in the Rilpivirine KDMF to evaluate the safety and efficacy of the drug.

After submitting a Rilpivirine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Rilpivirine API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Rilpivirine suppliers with KDMF on PharmaCompass.

Rilpivirine NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rilpivirine as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Rilpivirine API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Rilpivirine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Rilpivirine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rilpivirine NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Rilpivirine suppliers with NDC on PharmaCompass.

Rilpivirine GMP

Rilpivirine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Rilpivirine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rilpivirine GMP manufacturer or Rilpivirine GMP API supplier for your needs.

Rilpivirine CoA

A Rilpivirine CoA (Certificate of Analysis) is a formal document that attests to Rilpivirine's compliance with Rilpivirine specifications and serves as a tool for batch-level quality control.

Rilpivirine CoA mostly includes findings from lab analyses of a specific batch. For each Rilpivirine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Rilpivirine may be tested according to a variety of international standards, such as European Pharmacopoeia (Rilpivirine EP), Rilpivirine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rilpivirine USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty